FindTrial
Sign In

The erarly diagnosis of testiculular damage and evaluation of surgical outcome in bilateral retractile testis by anti-mullerian hormone and inhibin B

The erarly diagnosis of testiculular damage and evaluation of surgical outcome in bilateral retractile testis by anti-mullerian hormone and inhibin B

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019328
Enrollment
Unknown
Registered
2018-11-06
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retractile testis

Interventions

retractile testis Group:Nil
control group:Nil

Sponsors

Shenzhen Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Retratile testis, which can be pulled down to the bottom of scrotum, and stop for a moment.

Exclusion criteria

Exclusion criteria: undescended testis, the creamasteric reflex, and DSD were exclude

Design outcomes

Primary

MeasureTime frame
AMH;Inhibin B;testosterone;testicular volume;—

Countries

China

Contacts

Public ContactZhilin Yang

Shenzhen Children's Hospital

yangzhilin207@163.com+86 18938690841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026